Cutting edge: HLA-b27 can form a novel β2-microglobulin-free heavy chain homodimer structure

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5045-5048

  Allen, Rachel L ^a,b   O'Callaghan, Chris A ^a   McMichael, Andrew J ^a   Bowness, Paul ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b Department of Pathology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CYSTEINE; EPITOPE; HLA B27 ANTIGEN; PEPTIDE;

ALPHA CHAIN; ANTIBODY LABELING; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISULFIDE BOND; HLA SYSTEM; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SPONDYLOARTHROPATHY;

ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BETA 2-MICROGLOBULIN; CELL LINE; CELL MEMBRANE; CYSTEINE; DIMERIZATION; DISULFIDES; HLA-B27 ANTIGEN; HUMANS; PRECIPITIN TESTS; PROTEIN CONFORMATION; TRANSFECTION;

EID: 0033136630     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Brewerton, D. A., M. Caffrey, F. D. Hart, D. C. O. James, A. Nichols, and R. D. Sturrock. 1973. Ankylosing spondylitis and HL-A27. Lancet 1:904.
2. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
3. Benjamin R., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11:137.
4. 2m. J. Clin. Invest. 98:2746.
5. Khare, S. D., M. J. Bull, J. Hanson, H. S. Luthra, and C. S. David. 1998. Spontaneous inflammatory Disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J. Immunol. 60:101.
6. 2 microglobulin negative cells. J. Exp. Med. 176:829.
7. el-Zaatari, F. A., K. C. Sams, and J. D. Taurog. 1990. In vitro mutagenesis of HLA-B27: amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substitution of the side chain. J. Immunol. 144:1512.
8. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321.
9. MacLean, L., M. Macey, M. Lowdell, S. Badakere, M. Whelan, D. Perrett, and J. Archer. 1992. Sulphydryl reactivity of the HLA-B27 epitope: accessibility of the free cysteine studied by flow cytometry. Ann. Rheum. Dis. 51:456.
10. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429.
11. McMichael, A. J., and C. A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med. 187:1367.
12. Wilson, J. D. K., G. S. Ogg, R. L. Allen, P. J. R. Goulder, A. Kelleher, A. K. Sewell, C. A. O'Callaghan, S. L. Rowland-Jones, M. F. C. Callan, and A. J. McMichael. 1998. Oligoclonal expansions of CD8+ T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785.
13. Maziarz, R. T., J. Fraser, J. L. Strominger, and S. J. Burakoff. 1986. The human HLA-specific monoclonal antibody W6/32 recognises a discontinuous epitope within the α 2 domain of murine H-2Db. Immunogenetics 24:206.
14. Colbert, R. A., S. L. Rowland-Jones, A. J. McMichael, and J. A. Frelinger. 1994. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity 1:121.
15. k class I MHC molecules J. Immunol. Methods 209:25.
16. Peh, C. A., S. R. Burrows, M. Barnden, R. Khanna, P. Cresswell, D. J. Moss, and J. McCluskey. 1998. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8:531.
17. Raposo, G., H. M. van Santen, R. Leijendekker, H. J. Geuze, and H. L. Ploegh. 1995. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-golgi intermediate compartment. J. Cell Biol. 131:1403.
18. 2-microglobulin dissociation. J. Immunol. 151:159.
19. Urban, R. G., R. M. Chicz, W. S. Lane, J. L. Strominger, A. Rehm, M. J. H. Kenter, F. G. C. M. Uytdehaag, H. Ploegh, B. Uchanska-Ziegler, and A. Ziegler. 1994. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA 91:1534.
20. Madrigal, J. A., M. P. Belich, R. J. Benjamin, A.-M. Little, W. H. Hildebrand, D. L. Mann, and P. Parham. 1991. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surface of activated T and B cells. J. Exp. Med. 174:1085.
21. 2m-free MHC class I molecules induced on activated T cells. Cell. Immunol. 142:103.
22. Neumuller, J., M. Fischer, and R. Eberl. 1993. Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis. Rheumatol. Int. 13:163.
23. Kirveskari, J., H. Kellner, M. Wuorela, H. Soini, B. Frankenberger, M. Leirisalo-Repo, E. H. Weiss, and K. Granfors. 1997. False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction. Br. J. Rheumatol. 36:185.
24. Wuorela, M., S. Jalkanen, J. Kirveskari, P. Laitio, and K. Granfors. 1991. Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect. Immun. 65:2060.
25. Gao, X. M., P. Wordsworth, A. J. McMichael, M. M. Kyaw, M. Seifert, D. Rees, and G. Dougan. 1996. Homocysteine modification of HLA antigens and its immunological consequences. Eur. J. Immunol. 26:1443.